Insider · CIK 0001732980
Jamil Farshchi
Files at EFX (EQUIFAX INC). First filing Nov 27, 2024, latest Feb 12, 2026.
In brief
Jamil Farshchi files SEC Form 4 as officer at EFX (EQUIFAX INC). Since Nov 27, 2024, Jamil Farshchi has reported 0 open-market buys worth $0 and 4 open-market sells worth $11M, the latest filed on Feb 12, 2026.
A track record needs three past buys with six months of prices behind them; Jamil Farshchi has 0, so none is measured yet.
The newest scored trade: sold $1.4M of EFX on Feb 10, 2026, filed Feb 12, 2026, scored 25 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $2.6M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EFX: EQUIFAX INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | EQUIFAX INC | $1.4M 7,380 shares | -16% | +16% from low-27% from high | |
| 18Weak | EQUIFAX INC | $1.2M 4,925 shares | -11% | +12% from low-18% from high | |
| 30Weak | EQUIFAX INC | $4.7M 18,911 shares | -33% | - | |
| 23Weak | EQUIFAX INC | $3.8M 14,716 shares | -30% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 11, 2026 | EFX EQUIFAX INC | 1,167 0.00% of outstanding | $233k | Feb 11, 2026 | $1.2M |
| Feb 10, 2026 | EFX EQUIFAX INC | 6,213 0.01% of outstanding | $1.2M | Feb 10, 2026 | none |
| Oct 27, 2025 | EFX EQUIFAX INC | 4,925 0.00% of outstanding | $1.2M | Oct 27, 2025 | none |
| Feb 12, 2025 | EFX EQUIFAX INC | 18,911 0.02% of outstanding | $4.7M | Feb 12, 2025 | $3.8M |
| Nov 26, 2024 | EFX EQUIFAX INC | 14,716 0.01% of outstanding | $3.8M | Nov 26, 2024 | none |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | EFX EQUIFAX INC | AGrant or award Common Stock | +14,221 | $0.00 | $0 | 54,090 | Feb 27, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +6,213 | $191.44 | $1.2M | 45,624 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | AGrant or award Common Stock10b5-1 | +4,667 | $0.00 | $0 | 50,291 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | FTax withholding Common Stock10b5-1 | -3,042 | $202.71 | $617k | 47,249 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -6,213 | $195.81 | $1.2M | 41,036 | Feb 12, 2026 |
| Feb 11, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -1,167 | $199.87 | $233k | 39,869 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -6,213 | $0.00 | $0 | 0 | Feb 12, 2026 |
| Oct 27, 2025 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +4,925 | $175.48 | $864k | 44,289 | Oct 28, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -4,925 | $238.94 | $1.2M | 39,364 | Oct 28, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -4,925 | $0.00 | $0 | 0 | Oct 28, 2025 |
| Feb 11, 2025 | EFX EQUIFAX INC | AGrant or award Common Stock10b5-1 | +2,373 | $0.00 | $0 | 41,027 | Feb 13, 2025 |
| Feb 11, 2025 | EFX EQUIFAX INC | FTax withholding Common Stock10b5-1 | -1,775 | $253.00 | $449k | 39,252 | Feb 13, 2025 |
| Feb 12, 2025 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +13,367 | $149.53 | $2.0M | 52,619 | Feb 13, 2025 |
| Feb 12, 2025 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +5,544 | $138.45 | $768k | 58,163 | Feb 13, 2025 |
| Feb 12, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -18,911 | $248.18 | $4.7M | 39,252 | Feb 13, 2025 |
| Feb 12, 2025 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -5,544 | $0.00 | $0 | 0 | Feb 13, 2025 |
| Feb 12, 2025 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -13,367 | $0.00 | $0 | 0 | Feb 13, 2025 |
| Feb 10, 2025 | EFX EQUIFAX INC | AGrant or award Common Stock | +3,707 | $0.00 | $0 | 38,654 | Feb 12, 2025 |
| Feb 10, 2025 | EFX EQUIFAX INC | AGrant or award Stock Option/Right to Buyderivative | +11,910 | $0.00 | $0 | 11,910 | Feb 12, 2025 |
| Nov 26, 2024 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +9,171 | $127.37 | $1.2M | 43,803 | Nov 27, 2024 |
| Nov 26, 2024 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +5,545 | $138.45 | $768k | 49,348 | Nov 27, 2024 |
| Nov 26, 2024 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -14,716 | $260.39 | $3.8M | 34,632 | Nov 27, 2024 |
| Nov 26, 2024 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -5,545 | $0.00 | $0 | 5,544 | Nov 27, 2024 |
| Nov 26, 2024 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -9,171 | $0.00 | $0 | 0 | Nov 27, 2024 |
Questions about Jamil Farshchi
Answered from the filings on this page, as of the latest one.
Is Jamil Farshchi buying or selling?
In the last 12 months Jamil Farshchi reported 0 open-market buys worth $0 and 2 open-market sells worth $2.6M on SEC Form 4; the latest was sold $1.4M of EFX on Feb 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Jamil Farshchi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jamil Farshchi has 0.
Where does Jamil Farshchi file Form 4?
Jamil Farshchi has filed Form 4 at EFX (EQUIFAX INC) as EVP, Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.